1. Introduction {#s0005}
===============

Population-based studies indicate a lifetime prevalence of psychoses above 3% ([@bb0190]). While one third of affected individuals experience psychotic symptoms for a short period of time, others are affected throughout their entire lives ([@bb0100]). Unfortunately, there is no way to predict, early on, which individuals will develop this incapacitating course. Identifying these individuals at illness onset is important as it could help provide better care to those most at risk.

Schizophrenia, and to a lesser extent other psychotic disorders, are associated with smaller gray matter volume, predominantly in the prefrontal cortex, but also in superior and medial frontal and temporal gyri, insula and thalamus ([@bb0075], [@bb0095], [@bb0105], [@bb0225]). Even at the first psychotic episode, patients already show thalamic, insular and hippocampal volume reductions and larger ventricular volume compared to healthy controls ([@bb0140], [@bb0205], [@bb0210], [@bb0235]).

Several structural Magnetic Resonance Imaging (MRI) studies have tried to use these brain measures at the time of the first episode to predict subsequent outcome. While many did not find significant differences between poor and good outcome patients ([@bb0165], [@bb0255]), others reported contradictory findings. A 1-year follow-up study found that first-episode schizophrenia (FE-SZ) patients with clinical deterioration had a smaller area of internal capsule compared to those with stable psychopathology, but no differences in either its volume or in any of the other 32 regions of interest (ROI) studied ([@bb0275]). Another short-term study found that volume of the dorsolateral prefrontal cortex was predictive of outcome at 1-year, but not at 2-years ([@bb0200]). Studies with longer follow-up periods -- 5 to 6 years -- more consistently found that smaller initial gray matter volume was predictive of poorer outcome at follow-up ([@bb0045], [@bb0150], [@bb0160]). This evidence suggests that evaluating outcome over longer follow-up periods could potentially improve the predictive power of brain measures.

The studies described above used a univariate approach to identify brain differences related to subsequent outcome. While this statistical approach allows for inferences about regional effects, it does not enable predictions at the level of the individual subject. More recently, machine-learning approaches have shown potential for clinical translation ([@bb0080]), and multivariate pattern recognition techniques have been applied to MRI data for the individualized prediction of clinical characteristics. Pattern recognition is a field within the area of machine learning concerned with automatic discovery of regularities in the data through the use of computer algorithms, and with using these regularities to classifying data into different categories ([@bb0030]). When applied to data such as structural MRI, brain scans are treated as spatial patterns, and pattern recognition models are used to identify statistical properties of the data, which in turn enable discrimination between groups of subjects, for example patients from healthy subjects ([@bb0115], [@bb0130], [@bb0180], [@bb0185]). This application has shown promising results. For example, even in first episode patients, multivariable models have been used to predict diagnoses with accuracies ranging between 79.3% and 91.5% ([@bb0120], [@bb0195], [@bb0240], [@bb0250], [@bb0245]). Furthermore, our own previous work has shown that MRIs obtained at time of the first psychotic episode (in a sample of 56 patients) could be used to predict illness course 6 years later with an accuracy of approximately 70% ([@bb0170]). This accuracy is substantially higher than that reported in an earlier one-year follow-up study that used pattern recognition to separate remitting (n = 15) and not remitting (n = 21) patients, which only achieved an accuracy of 58% ([@bb0285]). Although these results are modest, they support the potential clinical utility of biological brain markers for the prediction of outcome in schizophrenia.

One of the biggest challenges in the translation of neuroimaging findings into clinical practice is the need to validate these models across large independent samples and across data obtained from different MRI scanners ([@bb0220]). This is essential to demonstrate robustness in the variability introduced by factors such as scanner type, acquisition protocols and clinical evaluation. In addition, combining multiple samples increases the overall sample size, overcoming a limitation common to many neuroimaging studies. In fact, recent studies on Alzheimer\'s disease ([@bb0065], [@bb0070], [@bb0145]) and major depression ([@bb0175]) have used multi-center data and shown very high classification accuracies, ranging from \~ 80% to \~ 90%.

In this study we combined five independent structural MRI datasets from leading international centers for the study of psychosis (Institute of Psychiatry, Psychology and Neuroscience, London; University Medical Center, Utrecht; University of São Paulo, São Paulo; University of Cantabria, Santander; University of Melbourne, Melbourne). We included both affective and non-affective psychoses for two reasons: first, because several brain alterations are common to both; and second, because the ability of the MRI obtained at first episode to predict subsequent outcome should be tested across all psychoses, since more specific diagnoses are still uncertain when the MRI is acquired. We had three main aims: 1) to investigate whether structural MRI data from multiple centers can be combined to create a machine-learning model able to predict a strong biological variable like sex; 2) to replicate our previous finding from the London dataset that an MRI scan obtained at first episode can be used to predict subsequent illness course in four independent datasets ([@bb0170]); and finally, 3) to test whether these datasets can be combined to generate multicenter models with better accuracy in the prediction of illness course.

We hypothesized that, by combining data from different scanners and thus creating larger samples, it would be easier for the classifier to learn the classification task and for any scanner or site effects to be considered as noise, thus resulting in a more robust model and in higher classification accuracy (of both sex and outcome). We therefore expected that the models would replicate our previous finding that an MRI at first episode can be used to predict subsequent illness course, with significant accuracy.

2. Method {#s0010}
=========

2.1. Samples {#s0015}
------------

The overall sample comprised five datasets of patients (total n = 389) who had an MRI scan at the time of their first episode of any psychotic illness (including DSM-IV diagnosis of schizophrenia, schizophreniform disorder, schizotypal disorder, schizoaffective disorder, depression with psychotic symptoms, bipolar affective disorder, psychosis not otherwise specified), and who were followed up over a period ranging between three and seven years, when clinical outcome was evaluated. The samples included: n = 67 patients from the University Medical Center Utrecht (UMCU, The Netherlands) ([@bb0040]); n = 97 patients from the Institute of Psychiatry, Psychology and Neuroscience (IoPPN, London, United Kingdom) ([@bb0170]) from the initial study; n = 64 patients from the University of São Paulo (São Paulo, Brazil) ([@bb0210]); n = 107 patients from the University of Cantabria (Santander, Spain) ([@bb0055]); and n = 54 patients from the University of Melbourne (Melbourne, Australia) ([@bb0265]). The samples were derived from well-established studies, the main findings of which have been extensively published elsewhere. All subjects were scanned in a 1.5 T scanner (protocol details provided below). All participants gave written informed consent and local ethics committees approved the studies.

2.2. Sex groups {#s0020}
---------------

Although classifying sex is a complex task, the classification problem is relatively easy, as sex can be unequivocally determined and brain sexual dimorphisms is well established, particularly in the Heschl\'s gyrus, the planum temporale and the hippocampal formation ([@bb0090]). The dataset used in this analysis included 133 females and 256 males. To create a model based on a balanced dataset, all 133 female subjects were included, independently of their illness course, together with a subset of 133 males randomly selected from the overall sample, matched for site. To compare multi-center models to single-center models, five single-center models were created with all the females and a random selection of males. To reduce chances of selection bias, we built one hundred models with these random selections. Cross-validation (see details below) was used to estimate average prediction percentages.

2.3. Outcome groups {#s0025}
-------------------

All centers provided information on the number of episodes that patients had experienced during the follow-up period and on whether they had achieved remission. Centers differed in the instruments used to evaluate illness course during follow-up ([Table 2](#t0010){ref-type="table"}). These included: World Health Organization Life Chart ([@bb0280]), Schedules for Clinical Assessment in Neuropsychiatry (SCAN ([@bb0270])), Positive and Negative Syndrome Scale, (PANNS ([@bb0125])), Comprehensive Assessment of Symptoms and History, (CASH ([@bb0015])) and Scale for the Assessment of Negative Symptoms (SANS, ([@bb0010])). Illness course was therefore classified using a conservative approach into two groups that captured patient with an "extreme" type of outcome: one group with a "continuous" illness course (no remission of symptoms of \> 6 months); and one group with a "remitting" illness course (one or more periods of remission of at least 6 months, and no episode lasting longer than 6 months). All patients who had experienced only a single psychotic episode (lasting no longer than 6 months) were included in the "remitting" group. Three centers (London, Utrecht, São Paulo) provided additional information on duration of the psychotic episodes. Patients who were neither in the continuous nor in the remitting group (i.e., had a remission and an episode lasting longer than 6 months) were excluded from further analyses on illness course (although they were included in the sex-based analyses). Within the London, Melbourne and Utrecht samples, 59%, 56% and 58% of all patients were included respectively. In the samples from Santander and São Paulo the percentages were 53% and 45% of the entire samples respectively. In total, 94 continuous patients and 118 remitting patients were included in the outcome analyses. Most patients had a diagnosis of schizophrenia (n = 114), followed by schizophreniform disorder and schizoaffective disorder (n = 39). Other diagnoses included bipolar affective disorder (n = 13), brief psychotic disorder (n = 5) and depression with psychotic symptoms (n = 9). The mean duration of follow-up in years was 6.3 (SD = 2.2), 4.9 (SD = 0.8), 7.0 (SD = 1.4), 3.0 (SD = 0.0) and 3.7 (SD = 0.6) respectively for London, Utrecht, Melbourne, Santander, and São Paulo.

After excluding patients who could not be classified as either continuous or remitting, the sample included 141 male patients (66 remitting and 75 continuous) and 71 females (52 remitting and only 19 continuous). To model less heterogeneous samples, we only included male patients, since the number of females per illness-course group per center was very small, and the samples size would have been too small to create a female-only model (see [Table 1](#t0005){ref-type="table"} for details).

2.4. MRI protocols and processing {#s0030}
---------------------------------

All images were acquired on 1.5-Tesla scanners (see [Table 3](#t0015){ref-type="table"}). The T1-weighted images were pre-processed according with the same protocol. Scans were manually oriented into MNI space, after which a non-uniformity correction was applied to remove radio frequency (RF) field inhomogeneity ([@bb0230]). Spatially normalized gray matter probabilities were obtained by running "segment" in SPM8 ([@bb0020]). This method segments, spatially normalizes (modulated normalized) and bias-corrects (10 full width half maximum (FWHM) 150 mm) all brains into the same space and dimensions (dimension: 91 × 109 × 91; voxel size: 2 × 2 × 2 mm). To reduce noise, all scans were smoothed with a 4-mm FWHM Gaussian kernel.

To ensure that only actual gray matter was included in the analysis, voxels with gray matter probabilities below 0.03 were excluded from the analysis. This resulted in 170,000 voxels or features per subject being included in the analyses.

2.5. Pattern recognition analyses {#s0035}
---------------------------------

All models were created using a linear Support Vector Machine (SVM) ([@bb0260]), which is a supervised machine learning method commonly applied to binary classification problems in neuroimaging ([@bb0130], [@bb0185]). In supervised learning approaches, a predictive function is "learned" from labeled training data, which is a data set consisting of examples (e.g. gray matter patterns) and labels (e.g. patients or healthy controls). The binary problem in this case consists of classification of two previously defined groups, for example, female vs. male or remitting vs. continuous. Every subject is represented by its gray matter probability map, which defines a high dimensional feature vector (in which each voxel in the map corresponds to a feature in the feature-vector). In order to build the binary classifier, the labeled data are used to create a model or decision boundary based on training examples (such as gray matter probability maps from remitting and continuous course patients). In the linear case, this decision boundary corresponds to a hyperplane in the voxel space. The SVM finds the hyperplane that has the largest margin or separation between the two groups, also known as optimal hyperplane ([@bb0260]). The advantages of SVM compared to other classification techniques are its scalability and computational efficiency in higher dimensional problems.

A pre-existing implementation ([@bb0050]) of LIBSVM in Matlab (version 2009b) was used to compute models with a linear kernel. The parameter C was determined through nested cross validation. Nested cross validation involves one more loop than normal cross validation (explained below). The inner loop is used for optimizing model parameters and the outer loop is used to estimate model performance based on the test subjects, which are not used during the parameter optimization process.

Cross validation is a technique that estimates model performance using parts of the sample for training and testing. One part of the data is used for model estimation or training, and the other part is used for model testing. We elected to use a leave-two-out cross-validation framework (L2o), which allows for one subject of each class to be left out for testing, and for the remaining subjects from both classes to be used for model creation. In our multi-center models, the pairs that were left out were always from the same center. To obtain a more generalizable predictive value, we bootstrapped one hundred models: each time, a balanced group (as large as possible and with an equal number of subjects per class) was selected randomly, and then a completely independent leave-two-out cross-validation was performed. The average of all these bootstraps is what generated our predictive values.

2.6. Performance measures {#s0040}
-------------------------

In the sex classification model, the percentage of correctly classified females and males was estimated as the correctly classified females divided by all the females, and the correctly classified males divided by all the males.

The performance of the disease course models is reflected in a value per class: the positive and negative predictive accuracies (PPA and NPA). These are the ratios of correctly classified subjects in a specific class (true positives (TP) or true negatives (TN)), divided by all the subjects classified as belonging to that class (TP + false positives (FP) or TN + false negatives (FN)):$$\left. \text{Positive\ predictive\ accuracy} = {TP}/\left( {{TP} + {FP}} \right) \right.$$$$\left. \text{Negative\ predictive\ accuracy} = {TN}/\left( {{TN} + {FN}} \right) \right.$$

Significance of the models was determined by permutation testing. During the permutation test the labels were permuted one thousand times before re-training the models. The occurrence of accuracies equal to- or higher than- the accuracy of the model that is being tested were counted and then divided by the number of permutations, resulting in their p-value.

3. Results {#s0045}
==========

3.1. Sex classification models {#s0050}
------------------------------

The five single-center model accuracies are presented in [Table 4](#t0020){ref-type="table"} (a). The centers with the larger samples, London and Santander, performed 5--10% better than the other, smaller sample centers. The left part of the table contains the results of the multi-center support-vector-machine (SVM)-model, in which data from all centers were combined to train the models. The average accuracy in sex classification was 89% (range 81% to 94%) (males = 88%, females = 90%, p = 0.001). This multi-center model performed as well as the single-center model of the two larger samples (London 89% and Santander 88% vs. multi-center 89%). Interestingly, in the multi-center model, the accuracies of the centers with smaller samples (Utrecht and Melbourne) improved considerably, especially in the percentage of correctly classified females. Overall, the accuracy improved by 2% to 9% when compared to the single-center models. Moreover, the difference in classification accuracy of males and females was much smaller, indicating that the model was as likely to correctly classify a male as it was to correctly classify a female. The large differences we had seen in the smaller single-center models (Utrecht (20%), Melbourne (9%) and São Paulo (10%)) were reduced to only 6%, 5% and 0.3% respectively in the combined model.

3.2. Illness course classification in individual centers {#s0055}
--------------------------------------------------------

To investigate whether gray matter density at first episode could predict illness course, each dataset was first analyzed individually ([Table 4](#t0020){ref-type="table"}, b). When both male and female patients were included, the classification into continuous and remitting course was significant and above chance only in the sample from London at 68% and 70% (p \< 0.02 and p \< 0.007 respectively).

To investigate if a less heterogeneous sample would lead to better models, we built new models including only male patients ([Table 4](#t0020){ref-type="table"}, c). This increased the average accuracy in the Santander and São Paulo datasets by 11% and 15% respectively. However, it negatively affected the average classification accuracy in London (from 69% to 66%), while it did not significantly affect the accuracy in the datasets from Utrecht and Melbourne. Only the accuracy in the sample from São Paulo reached significance (p = 0.005), and the remitting patients from London were classified with a significance of p = 0.08. The lack of significance in the other samples may be due to the small sample sizes. The lack of improvement in accuracy after reducing data heterogeneity suggests that heterogeneity was not the only factor leading to the poor performance of these models. Reducing heterogeneity also led to smaller sample sizes, which could have negatively affected the results.

3.3. Illness course classification with multi-center models {#s0060}
-----------------------------------------------------------

In the third and last set of analyses we combined all data into multi-center models to classify illness course. Combining data from all centers into one model did not improve the results obtained from single-center models. The classification accuracy remained at chance level and did not reach significance ([Table 4](#t0020){ref-type="table"}, b).

The less heterogeneous multi-center model, including only male patients, showed that illness course in subjects from London and São Paulo was accurately classified with an average of 62% and 74% respectively (depicted in green and light blue in [Fig. 1](#f0005){ref-type="fig"}). Unfortunately, combining all five centers did not increase the accuracies in the others centers.

4. Discussion {#s0065}
=============

To the best of our knowledge, this is the first study that has investigated whether neuroimaging data obtained at the first psychotic episode from different scanners and with different protocols can be combined and used to accurately predict subsequent illness course. Our main finding is that combining multi-center neuroimaging data can lead to a single model that performs well (up to 90% accurate) when classifying strong, reliable biological outcomes such as sex. In contrast, our second main finding is that when classifying clinical characteristics, such as illness course, classification accuracies are only modest, and significant only in centers with most similar definitions of outcome. In addition, the results show that multi-center models can be used to increase the performance of smaller and heterogeneous samples. Taken together, these findings suggest that with larger samples, standardized clinical information and clear-cut outcome groups, multi-center-models have the potential to yield generalizable, clinically useful predictions.

4.1. Sex classification models {#s0070}
------------------------------

Can we pool data from different centers to increase classification accuracy and create better predictive models? The models based on relatively larger samples (London and Santander) correctly classified up to 90% of individuals from both sexes, while those based on smaller samples (Melbourne and São Paulo\'s) classified males with approximately 88% accuracy, and females with a lower accuracy (mean 79%). This could be due to the smaller number of females in the models: consistently with previous studies, models based on small samples show larger fluctuations in classification accuracies ([@bb0180]). We showed that by combining data from multiple centers (133 females and 133 males), the accuracy of the model improved (by approximately 8%), including in those centers with small samples (for example, the Utrecht sample only included 9 females). This confirms our hypothesis that combining datasets, even if acquired on different scanners and from different centers, can theoretically improve predictive models. The limitations of small sample sizes can therefore be overcome by combining multi-center-data, and unbalanced datasets (with fewer subjects of one group and more of the other group) can benefit from the more balanced distribution that derives from merging multiple datasets. However, it should be noted that our findings do not aim to provide information on brain sex dimorphism in psychosis, particularly in the absence of a non-psychosis comparison group, and only provide proof of concept for accurate multicenter classification models in the presence of a reliable outcome.

4.2. Illness course classification {#s0075}
----------------------------------

Our second main finding was that when creating single-center models to predict future outcome, only one center (London) achieved a significant accuracy ([@bb0285]). Classifying illness course is much more challenging than classifying sex. The lower accuracies observed in Utrecht, Melbourne, Santander and São Paulo are probably due to the small sample size in these centers (ranging between 10 and 16 subjects). In addition, illness course is much more heterogeneous than what can be captured by a simple continuous vs. remitting classification, and clinical differences between these two course types could be extremely subtle and difficult to identify. This highlights the importance of using strong, valid and standardized instruments for the classification of outcome ([@bb0080], [@bb0155]).

4.3. Multi-center illness course classification {#s0080}
-----------------------------------------------

The same modest results were seen when data from the five centers were combined to predict illness course. Although classifying outcome is more complex than classifying sex, we still expected that increasing sample size would have overcome the potential variability in outcome.

This modest classification accuracy could reflect the poor classification accuracy of the single-center-illness-prediction models. It is possible that in small samples, differences between classes are not large enough to overcome sample variability (i.e. the signal-to-noise ratio was very low). Adding "low signal-to-noise centers" might have increased noise. Also, our multi-center models might have been more accurate with larger samples and if single-center models had a better performance. This would be consistent with what reported by [@bb0220], who examined the influence of noise and sample size in multicenter MRI studies.

4.4. Male-only multi-center illness course classification {#s0085}
---------------------------------------------------------

To investigate whether reducing patient heterogeneity improved the classification models, we repeated the illness course classification analyses including only male patients. Combining all males into a multi-center-illness-prediction model led to an average accuracy of 54% overall. This was slightly better than the accuracy achieved by the model that included both sexes. The sample from São Paulo showed a significant improvement in accuracy of 12% of PPA and 17% of NPA compared to the multi-center mixed-sex models (p \< 0.089 and p \< 0.02 respectively). São Paulo\'s continuous group contained mainly male subjects, and could have benefited most by the exclusion of female subjects. While a decrease in sample size typically leads to a decrease in accuracy, this may have been compensated by an increase in signal-to-noise ratio in the more homogeneous sample ([@bb0215]). This increased homogeneity when considering only male patients could be due to a combination of factors. For example, there is evidence of sex-specific brain abnormalities associated with schizophrenia, and of sex-specific differences in illness characteristics, with males being likely to have an earlier age of onset, to experience more severe symptoms and to relapse more frequently ([@bb0005], [@bb0035], [@bb0085], [@bb0135]). Single-sex models could therefore more easily find a "typical" predictive pattern in one sex group during the training process, which would be more difficult to obtain in the presence of sexual dimorphism.

4.5. Limitations {#s0090}
----------------

Together with the heterogeneity introduced by different neuroimaging acquisition parameters, the heterogeneity introduced by clinical factors may have played a major role in the accuracies we achieved. The instruments used to assess illness course differed across studies and this may have resulted in heterogeneous and overlapping patient groups. Furthermore, the length of follow up, although long for all groups, ranged from 3 to 7 years and one cannot exclude that illness course may become more established with time. Furthermore, some centers had more clinical information available (for example on duration of psychosis) which could have potentially allowed for more accurate decisions about illness course. This highlights the importance of gathering precise and standardized information on the duration and characteristics of each psychotic episode when classifying outcome, which could eventually result in better models.

Another limitation of this study is the size of the samples included in the analysis. Even though we had data from 5 centers, we decided to restrict our analyses only to those subjects with the two most extreme illness course types (remitting and continuous), which resulted in some centers having only a small sample size, with a particularly small number of female subjects. Finally, we only used one brain scan, and it is possible that a better prediction of illness course could be achieved by measuring change over time or studying trajectories of change ([@bb0060]).

5. Conclusion {#s0095}
=============

In summary, we provide proof of concept that combining multi-center MRI data to create a single, well performing model is possible. Theoretically, multi-center models could lead to more robust classification accuracy than models based on just a single center when using brain structure to predict illness course or diagnosis, which would be more generalizable to new patient samples. Multi-center models would consider scanner and acquisition protocols as noise and find effects common to all centers, reducing the risk of misclassification. However, the effect within each single center needs to be strong enough to contribute to the multi-center model. This effectively means that a center has to contribute a sample that is large or homogeneous enough to individually classify with significant accuracy, in order to be of use in generating robust multi-center models.
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###### 

Demographic information on the samples.

Table 1

                                                              Institute of Psychiatry, Psychology and Neuroscience King\'s College London   University Medical Center Utrecht   University of Melbourne   University of Cantabria, Santander   University of São Paulo                                                       
  ----------------------------------------------------------- ----------------------------------------------------------------------------- ----------------------------------- ------------------------- ------------------------------------ ------------------------- ------------ ------------ ------------ ------------ ------------
  Clinical course (**R**emitting/**C**ontinuous)              **R**                                                                         **C**                               **R**                     **C**                                **R**                     **C**        **R**        **C**        **R**        **C**
   Patients (males)                                           27 (13)                                                                       30 (22)                             15 (14)                   24 (21)                              16 (9)                    14 (12)      41 (21)      16 (12)      19 (9)       10 (8)
   Age in years (SD)                                          28.1 (6.3)                                                                    29.2 (9.7)                          22.2 (3.9)                24.6 (5.3)                           21.3 (3.6)                21.6 (3.1)   31.4 (9.0)   29.8 (9.5)   26.2 (8.8)   31.7 (9.2)
   DUP in days (SD)                                           245 (825)                                                                     579 (1052)                          144 (190)                 243 (425)                            --                        --           373 (577)    229 (281)    59 (82)      122 (199)
   Schizophrenia diagnosis[a](#tf0005){ref-type="table-fn"}   9                                                                             22                                  12                        23                                   0                         10           22           10           1            5
  Sex (**M**ales/**F**emales)                                 **M**                                                                         **F**                               **M**                     **F**                                **M**                     **F**        **M**        **F**        **M**        **F**
   Whole original sample[b](#tf0010){ref-type="table-fn"}     61                                                                            36                                  58                        9                                    37                        17           62           45           38           26

The number of patients diagnosed with schizophrenia at follow-up per sample per group.

Sample including all patients with Remitting, Continuous and Intermediate course.

###### 

Questionnaires used in each center.

Table 2

              DSM-IV/DSM-V   ICD-10   PANSS   WHO life chart   SCAN   CASH   GAF   SAPS   SANS
  ----------- -------------- -------- ------- ---------------- ------ ------ ----- ------ ------
  London      x              x                x                x                          
  Utrecht     x                       x                               x      x            
  Melbourne   x                               x                                           
  Santander   x              x                                                     x      x
  São Paulo   x                       x                                      x            

###### 

Scanner-protocols and scanner-type per center.

Table 3

                                      Field strength   System                           Sequence                                Flip angle   Repetition time ms   Echo time (TE) ms   Voxel dimension (mm)[b](#tf0020){ref-type="table-fn"}          
  ----------------------------------- ---------------- -------------------------------- --------------------------------------- ------------ -------------------- ------------------- ------------------------------------------------------- ------ ------
  University of Cantabria Santander   1.5 T            General Electric SIGNA System    SPGR[a](#tf0015){ref-type="table-fn"}   45°          24                   5                   1.02                                                    1.02   1.50
  University Medical Center Utrecht   1.5 T            Philips                          Fast field echo                         30°          30                   4.6                 1.00                                                    1.20   1.00
  The University of Melbourne         1.5 T            General Electric SIGNA System    SPGR[a](#tf0015){ref-type="table-fn"}   30°          14.3                 3.3                 0.94                                                    0.94   1.50
  Kings College London                1.5 T            General Electric SIGNA Systems   SPGR[a](#tf0015){ref-type="table-fn"}   20°          13.8                 2.8                 0.94                                                    1.50   0.94
  University of São Paulo             1.5 T            General Electric SIGNA System    SPGR[a](#tf0015){ref-type="table-fn"}   20°          21.7                 5.2                 0.86                                                    0.86   1.50

Spoiled gradient recalled acquisition in steady state.

All the scans had a coronal acquisition orientation.

###### 

Results of the classification models. The right hand side shows accuracies of the single-center models and the left hand side shows the accuracies of the multi-center models. Part (a) of the table shows the percentage of correctly classified males and females in the sex classification model; (b) shows the negative and positive predictive accuracies of the multi-center and single-center models on illness course classification; (c) shows the less heterogeneous illness course models, including only males.

Table 4

  \(a\) Gender classification, males vs. females                                                                                                                                                                                            
  ------------------------------------------------------------------------ -------------------- ---------------------- -------------------------------------- -------------------------------------- -------------------------------------- --------------------------------------
  London                                                                   61                   36                     93%[⁎](#tf0025){ref-type="table-fn"}   85%[⁎](#tf0025){ref-type="table-fn"}   90%[⁎](#tf0025){ref-type="table-fn"}   88%[⁎](#tf0025){ref-type="table-fn"}
  Santander                                                                62                   45                     91%[⁎](#tf0025){ref-type="table-fn"}   89%[⁎](#tf0025){ref-type="table-fn"}   87%[⁎](#tf0025){ref-type="table-fn"}   90%[⁎](#tf0025){ref-type="table-fn"}
  Utrecht                                                                  58                   9                      81%[⁎](#tf0025){ref-type="table-fn"}   87%[⁎](#tf0025){ref-type="table-fn"}   89%[⁎](#tf0025){ref-type="table-fn"}   69%
  Melbourne                                                                37                   17                     94%[⁎](#tf0025){ref-type="table-fn"}   89%[⁎](#tf0025){ref-type="table-fn"}   87%[⁎](#tf0025){ref-type="table-fn"}   78%[⁎](#tf0025){ref-type="table-fn"}
  São Paulo                                                                38                   26                     87%[⁎](#tf0025){ref-type="table-fn"}   86%[⁎](#tf0025){ref-type="table-fn"}   89%[⁎](#tf0025){ref-type="table-fn"}   79%[⁎](#tf0025){ref-type="table-fn"}
  Overall                                                                  256                  133                    90%[⁎](#tf0025){ref-type="table-fn"}   87%[⁎](#tf0025){ref-type="table-fn"}   88%[⁎](#tf0025){ref-type="table-fn"}   81%[⁎](#tf0025){ref-type="table-fn"}
                                                                                                                                                                                                                                            
  \(b\) Illness course classification, continuous vs. remitting patients                                                                                                                                                                    
                                                                                                                                                                                                                                            
  Entire sample                                                            Multi-center model   Single center models                                                                                                                        
                                                                                                                                                                                                                                            
                                                                           N continuous         N remitting            PPA                                    NPA                                    PPA                                    NPA
                                                                                                                                                                                                                                            
  London                                                                   30                   27                     55%                                    55%                                    68%[⁎](#tf0025){ref-type="table-fn"}   70%[⁎](#tf0025){ref-type="table-fn"}
  Santander                                                                16                   41                     44%                                    45%                                    44%                                    42%
  Utrecht                                                                  24                   15                     49%                                    48%                                    48%                                    48%
  Melbourne                                                                14                   16                     52%                                    51%                                    54%                                    53%
  São Paulo                                                                10                   19                     56%                                    62%                                    61%                                    62%
  Overall                                                                  94                   118                    52%                                    52%                                    55%                                    55%
                                                                                                                                                                                                                                            
  \(c\) Illness course classification, continuous vs. remitting patients                                                                                                                                                                    
                                                                                                                                                                                                                                            
  Males only                                                               Multi-center model   Single center models                                                                                                                        
                                                                                                                                                                                                                                            
                                                                           N continuous         N remitting            PPA                                    NPA                                    PPA                                    NPA
                                                                                                                                                                                                                                            
  London                                                                   22                   13                     62%                                    62%                                    64%                                    67%
  Santander                                                                12                   21                     46%                                    45%                                    53%                                    54%
  Utrecht                                                                  21                   14                     45%                                    45%                                    47%                                    47%
  Melbourne                                                                12                   9                      55%                                    54%                                    53%                                    53%
  São Paulo                                                                8                    9                      68%                                    80%[⁎](#tf0025){ref-type="table-fn"}   75%                                    78%
  Overall                                                                  75                   66                     54%                                    54%                                    58%                                    60%

Significant models with p-value \< 0.001.

[^1]: Joint last authors.
